WHO Africa Region Addresses Strategies On Counterfeits, Malaria, Hepatitis 23/08/2016 by William New, Intellectual Property Watch 1 Comment The 47 members of the World Health Organization African region this week adopted or considered a series of measures aimed at fighting substandard and counterfeit medical products, eliminating malaria and viral hepatitis, and setting a global strategy and plan of action on ageing and health that includes a focus on non-communicable diseases. They also adopted a plan for disease outbreaks and health emergencies.
The Downfall Of Invention: A Broken Patent System 18/08/2016 by Intellectual Property Watch 1 Comment The cost of dozens of brand-name drugs have nearly doubled in just the past five years. Public outrage over drug prices extends from Capitol Hill to the presidential candidates to patients. In response, pharmaceutical executives are spending more on lobbying and marketing. Yet for all this attention, most of the proposed solutions for reducing prescription drug costs—tougher negotiations, appeals for transparent R&D costs or investigations into insurers—miss one of the primary sources of the problem: the way we award patents, writes Tahir Amin.
MSF Hearing On Opposition To Pfizer Pneumonia Patent In India 28/07/2016 by Intellectual Property Watch 3 Comments Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent opposition in March in India to prevent Pfizer from patenting a pneumonia drug and will defend its position in a hearing tomorrow at the Indian Patent Office.
US Senate Judiciary Chairman Questions High Cost Of Medicare Drug Coverage 27/07/2016 by Intellectual Property Watch 2 Comments United States Senate Judiciary Committee Chairman Charles Grassley, an Iowa Republican, has demanded answers from the government Medicare programme regarding the rapid rise in costs of coverage of Americans’ prescription drugs. The demand follows a press report showing an extremely high climb in costs for the so-called “catastrophic coverage” program.
Details Of September UN High-Level Meeting On Antimicrobial Resistance 27/07/2016 by William New, Intellectual Property Watch 1 Comment Details of the upcoming United Nations General Assembly High-Level Meeting on Antimicrobial Resistance (AMR) are coming clear after the preparation of a text laying out the specifics.
Many Hepatitis C Patients Do Not Have Access To Medicines In India, Group Says 27/07/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Despite being the global leader of generic drug manufacturing, access to hepatitis C treatment in India remains out of reach for a large portion of the population, a civil society group has said in a new paper. The authors call for India to work on a national programme of prevention and treatment of hepatitis, and warn against voluntary licences developed by multinational pharmaceutical companies.
Infojustice: NGO And Academics Letter To US Secretary Of State On Access To Medicines 26/07/2016 by Intellectual Property Watch, Intellectual Property Watch 3 Comments From Infojustice.org: Letter from 56 Non-profit Organizations and Academic Experts to Secretary Kerry Regarding State Department Pressure Against Access to Medicines Efforts
Officials Discuss Meeting Global Fund Target Of US$13B 26/07/2016 by Munyaradzi Makoni for Intellectual Property Watch 1 Comment DURBAN, South Africa – As the fund to help the world’s most suffering prepares for a conference hosted by Prime Minister Justin Trudeau and the government of Canada in September to raise US$13 billion for its 2017-2019 period, the prospect of failing to meet the target is unsettling for the civil society and the health community.
Swift Decision On Plain Packaging At WTO Unlikely; Ukraine Drops Out 26/07/2016 by Catherine Saez, Intellectual Property Watch 1 Comment As the list of countries adopting legislation making the packaging of tobacco products a lot less sexy is growing, the long-awaited decision of a World Trade Organization panel on Australia’s decision to enforce such legislation might not be coming before the end of the year. Meanwhile, one of the countries complaining about Australia’s legislation has left the fight.
MSF International Access Campaign Recruiting Executive Director Of Access Campaign 25/07/2016 by Intellectual Property Watch Leave a Comment The Médecins Sans Frontières (MSF) International Access Campaign is recruiting an Executive Director (ED) of the Access Campaign.